logo

Resverlogix Corp. (RVX.TO)



Trade RVX.TO now with
  Date
  Headline
1/18/2022 7:32:48 AM Resverlogix Commences Patient Enrollment And Dosing In Phase 2b Trial For Canadian-Developed COVID-19 Treatment